NCT03932435 - "Bioequivalence Test of Dong-a Bepotastine Besilate Tab and Twolion Tab" | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

May 28, 2019

Study Completion Date

May 28, 2019

Conditions

Healthy

Interventions

DRUG

Fisrt period TWLO_C

"First Period: Single oral administration of 1 tablet of Dong-a Bepotastine Besilate Tab(Bepotastine Besilate 10mg)"

DRUG

Fisrt period TWLO

"First Period: Single oral administration of 1 tablet of Twolion Tab(Bepotastine Besilate 10mg)"

OTHER

Washout period

7 days

DRUG

Second period TWLO_C

"Second Period: Single oral administration of 1 tablet of Dong-a Bepotastine Besilate Tab(Bepotastine Besilate 10mg)"

DRUG

Second period TWLO

"Second Period: Single oral administration of 1 tablet of Twolion Tab(Bepotastine Besilate 10mg)"

Trial Locations (1)

H Plus Yangji Hospital, Seoul

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY